CoChat
Sign Up
Cited by 26Gestational Diabetes Research and ManagementDiabetes Management and ResearchPregnancy and Medication Impact

Screening and Management of Gestational Diabetes in Mexico: Results from a Survey of Multilocation, Multi-Health Care Institution Practitioners

Open access
Dainelli, Livia, Prieto Patron, Alberto, Silva-Zolezzi, Irma, Sosa Rubi, Sandra G., Espino y Sosa, Salvador, Reyes Muñoz, Enrique, Lopez-Ridaura, Ruy, Detzel, Patrick·2018·Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
DOI 10.2147/dmso.s160658PMC PMC5896662
Open this paper in CoChat — free accountOpen PDF

Abstract

PURPOSE: To identify the most common practices implemented for the screening and treatment of gestational diabetes mellitus (GDM) and to estimate the GDM clinician-reported proportion as a proxy of the incidence in Mexico. MATERIALS AND METHODS: Three hundred fifty-seven physicians in four major cities were asked about their practices regarding GDM screening, treatment, clinical exams, and health care staff involved in case of GDM diagnosis, as well as the percentage of women with GDM they care for. Data management and statistical analyses were done with Stata 13. RESULTS: The overall GDM clinician-reported proportion was 23.7%. Regional differences were expected and consistent with the data on the epidemiology of the obesity in the country. The most common screening test was the oral glucose tolerance test 75 g one step (46.6% of total cases). Diet and exercise were sufficient to treat GDM in 40.6% of cases; the rest of the sample relied on some form of medication, especially oral hypoglycemic agents (63.0% of cases), insulin (22.0%), or a combination of these (13.0%). To educate women on how to measure glycemia and eventually take medications, an average of 2-3 hours were necessary. The three most common prenatal screening tests were the "no stress", the "Doppler ultrasound", and the "biophysical profile", respectively, taken at least once by 70%, 60%, and 45% of women. Among women who were prescribed insulin, only 37% managed to keep the initial prescribed dose during the whole pregnancy. CONCLUSION: The survey confirmed the expected incidence and gave interesting results on the treatment of GDM. The current Mexican guidelines seem to have been partially implemented in practice, and a coherent national strategy for GDM is still missing. More studies are encouraged to investigate this topic, with the aim to better understand the importance of the monetary cost of GDM, which is currently underestimated.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/dmso.s160658

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In 2017, data from four major cities in Mexico reported an overall predicted gestational diabetes mellitus prevalence of 23.7%.

    “The data were collected in 4 major cities in Mexico: (Mexico City, Guadalajara, Monterrey, and Merida) in 2017, and an overall predicted GDM prevalence at the level of 23.7% was reported [54].”

    From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [54]

    The Materials and methods section says the survey was conducted in Mexico City, Guadalajara, Monterrey, and Merida in June–July 2017. The Results section reports a total predicted GDM clinician-reported proportion of 23.7%. Calling that figure GDM prevalence omits the important qualifier that it was based on clinicians’ reports, not a directly measured population prevalence. Page numbers were not available in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

  • In Mexico, the most popular screening method is the 75 g one-step OGTT (46.6% of total cases).

    “According to Dainelli et al. the most popular screening method is the 75 g one- step OGTT (46.6% of the total cases) [54].”

    From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [54]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 28

  1. [1]Metzger BE Coustan DR Organising Committee. Summary and recommendations of the Fourth International Workshop Conference on Gestational Diabetes Diabetes Care 1998 21 Suppl 2 B161 B167 9704245
  2. [3]Avalos GE Owens LA Dunne F ATLANTIC DIP Collaborators Applying current screening tools for gestational diabetes mellitus to a European population: is it time for change? Diabetes Care 2013 36 10 3040 3044 23757431 PMC3781510
  3. [4]Silva-Zolezzi I Samuel TM Spieldenner J Maternal nutrition: opportunities in the prevention of gestational diabetes Nutr Rev 2017 75 Suppl1 32 50 28049748 PMC5437972
  4. [5]Forsbach G Contreras-Soto JJ Fong G Flores G Moreno O Incidence of gestational diabetes and macrosomic newborns in a Mexican population Diabetes Care 1988 11 3 235 238 3416676
  5. [6]Tamez Pérez HE Rodríguez Ayala M Treviño Hernández M Experiencia con un programa de escrutinio de diabetes gestacional [Experience with a screening program for gestational diabetes] Rev Invest Clin 1993 45 5 453 456 Spanish 8134726
  6. [7]Meza E Barraza L Martínez G Gestational diabetes in a Mexican-U.S. border population: incidence and epidemiology Rev Invest Clin 1995 47 433 438 8850140
  7. [8]López-de la Peña XA Cájero Avelar JJ De León Romo LF Incidence of gestational diabetes in a group of women receiving treatment at the Mexican Institute of Social Security in Aguascalientes, Mexico Arch Med Res 1997 28 2 281 284 9204622
  8. [9]Espinosa de los Monteros A Parra A Hidalgo R Zambrana M The after breakfast 50-g, 1-hour glucose challenge test in urban Mexican pregnant women: its sensitivity and specificity evaluated by three diagnostic criteria for gestational diabetes mellitus Acta Obstet Gynecol Scand 1999 78 4 294 298 10203295
  9. [10]Ramírez-Torres MA Gestational diabetes mellitus. Experience at a third level hospital [Diabetes mellitus gestacional. Experiencia en una institución de tercer nivel de atención] Ginecol Obstet Mex 2005 73 9 484 491 Spanish 16312274
  10. [12]López Caudana AE López Ridaura R González Villalpando C Prediction of alterations in glucose metabolism by glucose and insulin measurements in early pregnancy Arch Med Res 2011 42 1 70 76 21376266
  11. [13]Dueñas-García OF Ramírez-Torres A Diaz-Sotomayor M Rico-Olvera H Resultados perinatales de pacientes con diabetes gestacional diagnosticada con tres métodos diferentes [Perinatal outcomes of patients with gestational diabetes diagnosed by three different methods] Ginecol Obstet Mex 2011 79 7 411 418 Spanish 21966835
  12. [14]Reyes-Muñoz E Castellanos-Barroso Ramírez-Eugenio BY The risk of gestational diabetes mellitus among Mexican women with a history of infertility and polycystic ovary syndrome FertilSteril 2012 97 6 1467 1471 22503417
  13. [15]Reyes-Muñoz E Parra A Castillo-Mora A Ortega-González C Effect of the diagnostic criteria of the International Association of Diabetes and Pregnancy Study Groups on the Incidence of Gestational Diabetes Mellitus in Urban Mexican Women: a Cross-Sectional Study Endocr Pract 2012 18 2 146 151 21856596
  14. [17]Hernández-Higareda S Omar-AlejandroPérez-Pérez Luz-Ma-AdrianaBalderas-Peña Enfermedades metabólicas maternas asociadas a sobrepeso y obesidad pregestacional en mujeres mexicanas que cursan con embarazo de alto riesgo Cirugía y Cirujanos 2017 85 4 292 298 27955851
  15. [19]O’Sullivan JB Mahan CM Criteria for the oral glucose tolerance test in pregnancy Diabetes 1964 13 278 285 14166677
  16. [20]Metzger BE Gabbe SG Persson B International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy Diabetes Care 2010 33 7 676 682 20190296 PMC2827530
  17. [24]Spaight C Gross J Horsch A Puder JJ Gestational diabetes mellitus Novelties in Diabetes Karger Publishers Basel, Switzerland 2016 31 163 178 26824237
  18. [25]Dávila-Torres J González-Izquierdo JJ Barrera-Cruz A Obesity in México Rev Med Inst Mex Seguro Soc 2015 53 2 240 249 25760754
  19. [26]NCD Risk Factor Collaboration(NCD-RisC) Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants Lancet 2016 387 10026 1377 1396 27115820 PMC7615134
  20. [29]Lacaria E Lencioni C Russo L Selective screening for GDM in Italy: application and effectiveness of National Guidelines J Matern Fetal Neonatal Med 2015 28 15 1842 1844 25260129
  21. [30]Xu W Zhang H Paillard-Borg S Zhu H Qi X Rizzuto D Prevalence of overweight and obesity among Chinese adults: role of adiposity indicators and age Obes Facts 2016 9 1 17 28 26745807 PMC5644857
  22. [31]Zhu WW Yang HX Wei YM Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China Diabetes Care 2013 36 3 586 590 23193214 PMC3579369
  23. [37]Tarlov AR Ware JE Jr Greenfield S Nelson EC Perrin E Zubkoff M The medical outcomes study. An application of methods for monitoring the results of medical care JAMA 1989 262 7 925 930 2754793
  24. [38]Cameron AC Trivedi Pravin K 2010 Microeconometrics Using Stata, Revised Edition College Station, TX, USA Stata Press Regression Analysis of Count Data 2nd ed NY, USA Cambridge University Press 2013
  25. [39]Joe H Multivariate Models and Multivariate Dependence Concepts CRC Press Company Boca Raton, London, New York, Washington DC 1997
  26. [40]StataCorp Stata Base Reference Manual Release 14 Stata Press Publication, StataCorp LP College Station, TX, USA 2015
  27. [46]Corrado F Pintaudi B D’Anna R Santamaria A Giunta L Di Benedetto A Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy Diabetes Metab 2016 42 2 122 125 26718735
  28. [52]Zhan Y Xiang YM Qi WH Wang AM Chen WP Shao DH Remote fetal monitoring for gestational diabetes mellitus Acad J First Med Coll PLA 2004 24 9 1053 1054 Chinese 15447862

Cited by

Sorted by citations

Authors
Dainelli, L., Prieto Patron, A., Silva-Zolezzi, I., Sosa Rubi, S. G., Espino y Sosa, S., Reyes Muñoz, E., Lopez-Ridaura, R., & Detzel, P.
Affiliations
Nestlé (Switzerland) (CH)
Corresponding author
Dainelli, Livia
ORCID
Prieto Patron, Alberto
Venue
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Publisher
Informa UK Limited
Published
2018-04
Volume
Volume 11
Pages
105-116
ISSN
1178-7007 (ISSN-L)
DOI
10.2147/dmso.s160658
PMC
PMC5896662
OpenAlex
W2796351026
Cited by
26
References
5
Citations by year
2025: 2 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 8 · 2019: 4
FWCI
3.93
Type
journal article
Language
en
Open access
Licence
Locations
  • Diabetes Metabolic Syndrome and Obesity (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
gestational diabetes mellitus, GDM screening, GDM treatment, oral glucose tolerance test, insulin therapy, oral antidiabetic drugs, prenatal screening, Doppler ultrasound, fetal biophysical profile, physician practice, Mexico

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review